Table 1.
Patient characteristics. Patient s#7 was excluded from sample analysis later due to deviation of the protocol
| Patient | Age | Sex | Stoma | Cancer stage | Preop XRT | Cleaning prep | Oral antibiotics | Preparative antibiotic (IV) |
|---|---|---|---|---|---|---|---|---|
| 1 | 55 | M | Y | T3N1 | Y | Golytele | Erythomycin, Metronidazole | Gentamicin, Metronidazole |
| 2 | 53 | M | Y | T3N0 | Y | Golytele | Erythomycin, Metronidazole | Cefoxitin, Ampicillin |
| 3 | 66 | M | Y | T3N0 | Y | Mag Citrate | None | Cefoxitin |
| 4 | 49 | M | Y | T1N0 | N | Golytele | Erythomycin, Metronidazole | Cefoxitin, Ampicillin |
| 5 | 53 | F | Y | Anastomotic recurrence | N | MoviPrep | None | Cefoxitin |
| 6 | 65 | M | Y | T3bN1 | Y | Golytele | Erythomycin, Metronidazole | Cefoxitin, Ampicillin |
| 7 | 34 | M | Y | T3N1 | Y | MoviPrep | None | Cefoxitin |
| 8 | 50 | M | Y | T2N0 | N | Miralax, dulcolax | Neomycin, Metronidazole | Ertapenam |
| 9 | 68 | M | Y | T3N1 | Y | Miralax, dulcolax | Neomycin, Metronidazole | Ertapenam |
| 10 | 55 | M | Y | T3N1 | Y | Miralax, dulcolax | Neomycin, Metronidazole | Ertapenam |